Report Overview

United States interventional cardiology devices market is growing rapidly due to rising prevalence of coronary artery disease (CAD), increasing aging population, increasing patient awareness of cardiovascular diseases, technological advances in cardiac interventional devices, and increasing demand for non–invasive treatments. Conventional balloons, drug–eluting stents, guide catheters, embolic protection devices, and vascular occlusion devices are various types of devices used in CAD surgery.

United States Interventional Cardiology Devices Market - Industry Trends & Forecast Report, 2028

United States interventional cardiology devices market was worth USD 2.4 billion in 2021 and is further projected to reach USD 3.7 billion by the year 2028, exhibiting a CAGR of 6.4% in the forecast period. The surge in the development of the interventional cardiology devices market is a combination of factors such as the increasing prevalence of diabetes and hypertension. These are major risk factors driving the demand for cardiac intervention devices. Diabetes is likely associated with other conditions that increase the risk of coronary artery disease, and hyperglycemia damages the blood vessels that control the heart over time, boosting the sale of cardiac intervention devices. In addition, Interventional cardiology devices can be used to treat various heart and arterial problems, encouraging people around the world to choose the same. In addition, technological advances have significantly increased the market share of cardiac intervention devices.

An unhealthy diet, smoking, lack of exercise, and excessive alcohol consumption are the main behavioral risk factors for heart disease and stroke. Symptoms such as high blood pressure and obesity may experience by individuals. Therefore, this leads to cardiovascular disease. The development, precision, and reliability of minimally invasive coronary stents have been made possible by frequent technological advances. This has the potential to increase adoption rates and drive market growth. In addition, the large number of patients suffering from coronary artery disease leads to strong demand for coronary intervention surgery, driving the growth of the cardiac intervention device market. Key players are focusing their efforts and initiatives on the development of minimally invasive coronary stents to meet the growing demand from patients, thereby driving market demand for cardiac interventional devices. The rapidly expanding elderly population, increasing patient awareness of the cardiovascular disease, and the growing need for patient monitoring and treatment are driving the growth of the US cardiac interventional device market. Other factors driving market expansion include the development of more sophisticated and innovative cardiovascular devices and the ease with which regulatory approvals can be obtained.

Interventional Cardiology Devices – Overview

Interventional cardiology deals with the use of catheters to treat heart problems. In this procedure, a device such as a balloon, stent, catheter, or other device is inserted into the femoral artery or other large peripheral artery or vein, and a cannula is inserted into the heart under x-ray guidance. In addition, a variety of interventional cardiovascular devices have been used to treat peripheral vascular problems that affect the circulatory system and can cause plaques to accumulate in the arteries of the extremities. Catheters, balloons, stents, and filters are some of the cardiac intervention devices on the market. Cardiovascular disease is the leading cause of death worldwide, killing an estimated 17.9 million people each year. Coronary and vascular diseases are all classified as cardiovascular diseases. Heart attacks and strokes cause more than four in five deaths from cardiovascular disease, and one–third of these deaths occur before the age of 70.

United States Interventional Cardiology Devices Market – Market Trends & Forecast Report 2028

Growth Drivers

Growing Patient Awareness of Cardiovascular disease and demand for advanced Treatments

Increasing patient awareness of the cardiovascular disease and the increasing need for patient monitoring and treatment are driving the US interventional heart disease device market growth. Various government, non–governmental, educational, and key market players have launched public awareness campaigns to raise awareness of illness and treatment and use more advanced techniques and procedures in healthcare facilities. The development of minimally invasive coronary stents, high precision, and higher reliability is made possible by frequent technological advances. This has the potential to improve market growth by increasing adoption rates in patients. Key players are focusing their efforts and initiatives on the development of minimally invasive coronary stents to meet the growing demand from patients, thereby driving market demand for interventional cardiology devices.

Restraints

Stringent regulatory requirements and High Cost of the Devices

High device costs, strict regulatory requirements, and the presence of effective first-line treatments can be seen as barriers to the growth of the United States Interventional Cardiology Devices Market. Legal requirements for affiliation of the medical device are complex and subject to change as needs change. These regulations are complex mainly due to the relevant legal aspects. The quality and performance of medical devices is a necessary aspect that requires various evaluation tests to go through to ensure public safety. Therefore, complex and stringent medical device affiliation standards are hampering the industry growth of the US United States Interventional Cardiology Devices Market to some extent.

Impact of COVID–19 on United States Interventional Cardiology Devices Market

COVID–19 has had a global impact on all aspects of the medical device industry, including the cardiac interventional device market. Despite the availability of emergency and outpatient services in the Department of Cardiology, the number of patient visits to hospitals has declined significantly over the past year, which negatively impacts the demand for cardiac intervention devices in some countries. National blockades and social distance measures have significantly reduced the number of patient visits, further reducing sales of cardiac intervention devices. Many cardiac equipment companies, including Boston Scientific, Medtronic, and Abbott, have reported lower revenues in the second and third quarters of 2020. However, healthcare spending has increased as a result of the COVID–19 pandemic's heightened emphasis on the value of public healthcare institutions.

Additionally, the COVID–19 vaccine entered the market, and fewer cases of COVID–19 are anticipated in the near future. As a result, the manufacturing facility for peripheral vascular devices and interventional cardiology will be completely reopened. By early 2022, this is expected to help restore the cardiac intervention market. Companies that manufacture interventional cardiology and peripheral vascular devices focus on protecting employees, work, and supply from responding to sudden events and implement new work practices as COVID–19 cases begin to decline.

United States Interventional Cardiology Devices Market – By Product

By product, the United States interventional cardiology devices Market is segmented into angioplasty balloons, angioplasty stents, structural heart devices, catheters, plaque modification devices, hemodynamic flow alteration devices, and others. Interventional angioplasty stents dominated the interventional cardiology device market in the product segment during the prediction interval. A report from the Centers for Disease Control and Prevention stated that coronary heart disease is common nowadays, and in 2020, 382,820 people died due to this in the US.

In addition to that, 20.1 million adults from age 20 or older have coronary artery disease (CAD) currently, according to CDC. The huge rise in coronary artery disease will positively impact the market for interventional Cardiology stents. The demand for angioplasty increases as the number of patients with chronic diseases increases. As the number of patients with coronary heart disease increases, so makes the demand for stents for interventional cardiology. As a result, the adoption rate of interventional heart disease stents will increase, driving segment growth over the predicted period. Angioplasty catheters are expected to grow rapidly during the prediction interval. This segment is driven by the rising prevalence of various chronic heart diseases and an increasingly elderly population. The angioplasty catheter market is growing as per the demand for minimally invasive surgery in emerging markets and the development of improved cardiovascular devices.

Competitive Landscape

The market is reasonably fragmented due to the presence of several local Players. These market players are striving to gain higher market share by adopting a variety of marketing strategies, including new product launches, investments, partnerships, and mergers and acquisitions. Companies are also investing in the development of improved products. In addition, they are also focusing on competitive prices. The key players of the United States Interventional Cardiology Devices Market are Abbott Laboratories, Inc., B. Braun Medical Inc., Biotronik, Inc., Boston Scientific Corporation, Cardinal Health, Inc., Cook Medical Inc., Cordis Corporation, Edwards LifeSciences Corporation, Medtronic USA, Inc., Terumo Americas Holding Inc.

Recent Development

• In February 2022, Medtronic Announced US FDA Approval for Freezor ™ and Freezor Extra Cardiac Cryoablation Focal Catheter.

• In September 2020, the Fourth generation MitraClip™ Transcatheter Mitral Valve Repair System in 2019 received US Food and Drug Administration (FDA) approval and has now received CE Mark.

Scope of the Report

By Product

• Angioplasty Balloons

  • Old/Normal Balloons

  • Drug–eluting Balloons

  • Cutting and Scoring Balloons

• Angioplasty Stents

  • Drug–eluting Stents

  • Bare–metal Stents

  • Bio absorbable Stents

• Structural Heart Devices

  • Aortic Valve Therapy Devices

  • Other Therapy Devices (Mitral valve, pulmonary valve and tricuspid valve and left atrial appendage therapy devices)

• Catheters

  • Angiography Catheters

  • Guiding Catheters

  • IVUS/OCT Catheters

• Plaque Modification Devices

  • Atherectomy Devices

  • Thrombectomy Devices

• Hemodynamic Flow Alteration Devices

  • Embolic Protection Devices

  • Chronic Total Occlusion Devices

• Other Devices

  • Guidewires

  • Vascular Closure Devices

  • Introducer Sheaths

  • Hemostasis Valves

  • Balloon Inflation Devices

By End User

· Hospitals

· Ambulatory Surgical Centers

· Others